2022-502843-36-00已完成1 期
A positron emission tomography (PET) study to assess where the radiotracer [11C]AZ14132516 goes in the body following administration to healthy participants
AstraZeneca AB, AstraZeneca AB1 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2023年4月3日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 9
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
AstraZeneca Clinical Study Information Center
Scientific
AstraZeneca AB
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Brain imaging of the adenosine A2A receptor in schizophreniaSchizophreniaISRCTN05808181King's College London (UK)18
已完成
不适用
Positron emission tomography (PET) measurement of the displaceability of [11C]FLB 457 from extra-striatal dopamine D2 receptors in maISRCTN23418225Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)16
招募中
2 期
Brentuximab Vedotin in combination with donor lymphocyte infusions for Hodgkin lymphoma relapsing or persisting after allogeneic stem cell transplantatioHodgkin lymphomaACTRN12619000581167Melbourne Health10
已完成
1 期
A PET (positron emission tomography) clinical research study using prostate specific membrane antigen (PSMA) targeted tracer, 89Zr-Df-IAB2MProstate cancer / Urothelial carcinoma / Renal cell carcinoma / Testicular cancerJPRN-UMIN000015356niversity of Tsukuba15
尚未招募
3 期
A Randomized control study and Meta-analysis comparing PET, CT and MRI scans for initial assessment of oral cancersCTRI/2021/12/038989ALL INDIA INSTITUTE OF MEDICAL SCIENCES RAIPUR